The contribution of S1P in cells is regulated by its synthesis catalyzed by SPHKs and catabolism by S1P phosphatases or S1P lyase (S1PL); thus the combination treatment of S1P synthesis inhibition together with its catabolism promotion may bring potential benefits for tumor therapy [60]. Here, SGPL1 is linked to neoplasm.